Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ruboxistaurin in Type 2 Diabetic Nephropathy
NCT00044148Phase 2Completed
- Sponsor
- Chromaderm
- Start
- Jul 2002
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ruboxistaurin in diabetic nephropathy (DN), sponsored by Chromaderm. Started Jul 2002; status: completed.
02
Drugs
ruboxistaurin
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT00044148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044148.